Anxiety Disorders Terminated Phase 3 Trials for Zuclopenthixol (DB01624)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric PatientsTreatment